Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02060188
Title A Study of Nivolumab and Nivolumab Plus Ipilimumab in Recurrent and Metastatic Colon Cancer (CheckMate 142)
Acronym CheckMate142
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL | AUS

Facility Status City State Zip Country Details
Local Institution - 0028 Gilbert Arizona 85234 United States Details
Local Institution - 0004 Los Angeles California 90033 United States Details
Local Institution - 0001 San Francisco California 94115 United States Details
Local Institution - 0008 Atlanta Georgia 30322 United States Details
Local Institution - 0002 Boston Massachusetts 02114 United States Details
Local Institution - 0036 Boston Massachusetts 02114 United States Details
Allina Health System dba Virginia PIper Cancer Institute Minneapolis Minnesota 55407 United States Details
Local Institution - 0034 Minneapolis Minnesota 55407 United States Details
Local Institution - 0024 Durham North Carolina 27710 United States Details
Local Institution - 0029 Winston-Salem North Carolina 27103 United States Details
Local Institution - 0005 Portland Oregon 97225 United States Details
Local Institution - 0041 Allentown Pennsylvania 18103 United States Details
Local Institution - 0013 Pittsburgh Pennsylvania 15232 United States Details
Local Institution - 0006 Nashville Tennessee 37232 United States Details
Local Institution - 0003 Houston Texas 77030-4009 United States Details
Local Institution - 0040 Westmead New South Wales 2145 Australia Details
Local Institution - 0039 Southport Queensland 4215 Australia Details
Local Institution - 0037 Melbourne Victoria 3000 Australia Details
Local Institution - 0019 Brussels 1000 Belgium Details
Local Institution - 0018 Brussels 1090 Belgium Details
Local Institution - 0020 Leuven 3000 Belgium Details
Local Institution - 0027 Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 0016 Toronto Ontario M5G 1X5 Canada Details
Local Institution - 0025 Paris 75571 France Details
Local Institution - 0022 Dublin 4 0 Ireland Details
Local Institution - 0023 Dublin 9 0 Ireland Details
Local Institution - 0033 Galway 0 Ireland Details
Local Institution - 0030 Candiolo, Torino 10060 Italy Details
Local Institution - 0035 Modena 41124 Italy Details
Local Institution - 0032 Padova Padova Italy Details
Local Institution - 0012 Madrid 28009 Spain Details
Local Institution - 0010 Madrid 28050 Spain Details
Local Institution - 0011 Sevilla 41013 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field